Crossmark

Comparison of BARD®LIFESTREAM™ covered balloon-expandable stent versus GORE® VIABAHN™ covered self-expandable stent in treatment of aortoiliac obstructive disease: study protocol for a prospective randomized controlled trial (NEONATAL trial)

Crossref DOI link: https://doi.org/10.1186/s13063-022-06332-7

Published Online: 2022-05-12

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qi, Yuhan

Wang, Jiarong

Zhao, Jichun

Huang, Bing

Xiong, Fei

Du, Xiaojiong

Chen, Xiyang

Guo, Qiang

Wang, Tiehao

Yuan, Ding https://orcid.org/0000-0002-7430-9890
License Information

Text and Data Mining valid from 2022-05-12

Version of Record valid from 2022-05-12
More Information

Article History

Received: 25 October 2021

Accepted: 23 April 2022

First Online: 12 May 2022

Declarations

:

: The study was approved by the Ethics Committee on Biomedical Research, West China Hospital of Sichuan University (approval number: 2021-212) on 3 March 2021. Informed consent will be obtained from each participant or from each of the participants’ legally responsible relatives.

: Upon trial completion, the main manuscript with results, whether positive, negative, or neutral, will be submitted to a major clinical journal for peer review and publication.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below